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Abstract
Mycoplasma bovis is the causative agent of Mycoplasma bovis-associated disease (MbAD). Although the mechanisms
underlying M. bovis adherence to host cells is not clear, recent studies have shown that the cell surface protein a-enolase
facilitates bacterial invasion and dissemination in the infected host. In this study, we cloned, expressed and purified
recombinant M. bovis a-enolase and induced polyclonal anti-a-enolase antibodies in rabbits. M. bovis a-enolase was
detected in the cytoplasmic and membrane protein fractions by these antibodies. Triple immunofluorescence labeling
combined with confocal laser scanning microscopy (CLSM) revealed that the plasminogen (Plg) enhanced the adherence of
M. bovis to embryonic bovine lung (EBL) cells; the values obtained for adherence and inhibition are consistent with this
finding. Interestingly, we found that trace amounts of trypsin acted as a more effective enhancer of cell adherence than Plg.
Hence, our data indicate that surface-associated M. bovis a-enolase is an adhesion-related factor of M. bovis that contributes
to adherence by binding Plg.
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Introduction
The adherence of mycoplasmas to the host cell initiates
infection with bacteria of this genus [1]. Mycoplasma bovis is the
causative agent of Mycoplasma bovis-associated disease (MbAD) [2].
The bacterium was first isolated from a case of severe mastitis by
Hale in 1961 [3]. M. bovis, which causes pneumonia, otitis media
and arthritis in young calves, has been an important cause of
disease in North America,Europe and Asia [4–6]. M. bovis was first
isolated in the Hubei province of China in 2008 [6], but the
economic cost of MbAD has not been reported.
Plasminogen (Plg) is a single-chain glycoprotein (with a
molecular mass of 92 kDa) that is converted into plasmin in vivo
[7]. Many bacteria express surface structures that interact with Plg
and specific receptors on their cell surfaces enhance the activation
of Plg via Plg activators [8]. Many pathogens have been found to
capture Plg, which allows the bacteria to acquire surface-
associated proteolytic activity that may facilitate bacterial invasion
and dissemination in the infected host [9].
Recently, the glycolytic enzyme a-enolase, a non-classical Plg-
binding protein, has been found in many bacteria [9–12].
Prokaryotic a-enolase is a highly conserved protein that may
contribute to pathophysiological processes [13]. Research has
shown that the presence of bacterial surface a-enolase is closely
related to bacterial adherence to the host cell [14]. There is,
however, no evidence showing that M. bovis a-enolase (MbEno) is a
membrane protein related to M. bovis adherence to the host cell.
In this study, we found that M. bovis expresses several
plasminogen-binding proteins. We used recombinant M. bovis a-
enolase (rMbEno) to induce anti-a-enolase antibodies in rabbits to
facilitate characterization of the adherence properties of M. bovis to
embryonic bovine lung (EBL) cells. We also explored the role of a-
enolase as a Plg-binding protein in adherence and invasion of M.
bovis.
Results
Identification of enolase of M. bovis
The 1365-bp open reading frame (ORF) of a-enolase was
identified in the complete genomic sequence of M. bovis strain
Hubei. The ORF encoded a 454-amino-acid protein with a
theoretical molecular weight of 49369 Da and isoelectric point of
5.27 (Pepstats V6.0.1). The M. bovis a-enolase lacks classical
protein-sorting signals such as N-terminal signal peptides, hydro-
phobic domains, or a C-terminal LPXTGX motif (SOSUI). The
amino acid sequence was homologous to the a-enolase sequences
from a variety of species, as determined using a maximum-
likelihood analysis in MEGA4.0.2. The M. bovis Hubei a-enolase
identified showed more than 90% homology to M. bovis PG45
(E4PZX0), M. fermentans (E1PS24), M. agalactiae(A5IYA8), M.
hyopneumoniae (Q601S2) and M. gallisepticum (Q7NAY0), respective-
ly. In addition, the protein contained features typical of Plg-
binding-site motifs including lysine as the C-terminal residue
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motif (LYDENSKKY), as identified by UniProt (data not shown).
M. bovis a-enolase gene expression, and protein
purification
We designed primers to mutate TGA into TGG to obtain a
sequence that would be correctly expressed in E. coli. The
recombinant plasmid was digested with restriction enzymes to
verify the size of the insert DNA and that TGA (186 bp and
960 bp) had been successfully mutated into TGG.
Recombinant plasmids were transformed into E. coli BL21
(DE3) pLysS cells to obtain the recombinant fusion protein
designated His-rMbEno. His-tagged recombinant protein, purified
under non-denaturin conditions (using Ni-NTA HisNBind Resin)
had an apparent molecular weight of 72 kDa.
The a-enolase antibody
Ten days after the third immunization, the reactivity and
specificity of the rabbit antisera was tested by enzyme-linked
immunosorbent assay (ELISA) (Figure 1), Following purification
with Protein A sepharose, the serum, containing anti-rMbEno
polyclonal antibodies (2.0 mg/ml), was stored at 220uC.
Localization of M. bovis a-enolase
MbEno was detected in the cell-soluble cytosolic fraction
proteins (Figure 2. lane 2), in the cell-membrane-fraction proteins
(Figure 2. lane 3) and in whole-cell proteins (Figure 2. lane 4).
Bovine serum albumin (Figure 2. lane 1) and rMbEno (Figure 2.
lane 5) were employed as negative and positive controls,
respectively. This analysis, using anti-rMbEno antibodies, revealed
a strong reactivity to a protein of approximately 49 kDa,
suggesting that MbEno is present in both the membrane and the
soluble cytosolic protein fractions of M. bovis cells.
M. bovis and rMbEno bind plasminogen
MbEno was detected among the cell-membrane-fraction
proteins (Figure 3. lane 1) and cell-soluble cytosolic-fraction
proteins (Figure 3. lane 2). a-Enolase (commercial preparation)
(Figure 3. lane3), and rMbEno protein were used as positive
controls; BSA was employed as a negative control. We discovered
that several M. bovis proteins, including a-enolase, interacted with
Plg. The ability of rMbEno to bind Plg was tested by ELISA.
Increasing concentrations of Plg bound to immobilized rMbEno in
a dose dependent fashion (Figure 4A). A similar pattern was
observed when the wells were coated with M. bovis membrane
protein (Figure 4B).
Competition experiments were performed by adding rMbEno
rabbit polyclonal antibodies to the system. Addition of increasing
concentrations of anti-rMbEno antibodies decreased Plg binding
to M. bovis in a dose-dependent manner (Figure 4C). In the
presence of anti-M. bovis monoclonal antibody, however, no
obvious effects were observed (Figure 4D).
Adherence and inhibition assay
M. bovis has been shown to be capable of adhering to EBL cells,
and it has been further shown that membrane-protein antibodies
can significantly inhibit adherence of the bacterium to such cells.
Figure 1. Binding of anti-a-enolase antibodies to recombinant
Mycoplasma bovis a-enolase (rMbEno). ELISA plate wells were
coated with rMbEno (1.0 ug protein/well). Well contents were reacted
with serial dilutions (1/200 to 1/12800) of rabbit anti-a-enolase
antibodies, followed by anti-rabbit IgG(whole molecule) peroxidase
conjugate. Results were determined using o-phenylenediamine as a
substrate, as described in Materials and Methods.
doi:10.1371/journal.pone.0038836.g001
Figure 2. Localization of Mycoplasma bovis a-enolase. Western
blot analysis of bovine serum albumin (BSA; lane 1), cell soluble
cytosolic fraction proteins (lane 2), cell membrane fraction proteins
(lane 3), whole cell protein (lane 4), and purified recombinant
Mycoplasma bovis a-enolase blotted onto a nylon membrane and
detected with rabbit anti-recombinant enolase antibodies (lane 5)
blotted onto a nylon membrane and detected with rabbit anti-
recombinant enolase antibodies. M: protein marker.
doi:10.1371/journal.pone.0038836.g002
Figure 3. Ligand blotting assay. Membrane fraction proteins(lane
1), soluble cytosolic fraction proteins(lane 2), commercial a-enolase(lane
3), recombinant Mycoplasma bovis a-enolase (lane 4), and BSA(lane 5)
were blotted onto nitrocellulose membranes following SDS-PAGE, and
then incubated with plasminogen post-blocking. Bound plasminogen
was detected with sheep anti-plasminogen polyclonal antibody. M:
protein marker.
doi:10.1371/journal.pone.0038836.g003
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treated with Plg. We found that adherence to the cells was
inhibited by treatment with the anti-rMbEno antibody. In a
competition assay, however, we found that infection was not
inhibited by treatment with non-immune rabbit antibodies.
Furthermore, no fluorescence was detected when EBL cells were
incubated with the secondary antibody alone. The results of the
confocal laser scanning microscopy (CLSM), therefore, show that
a-Enolase is an M. bovis adhesion-related factor.
To further validate these experiments, adherence and inhibition
values were calculated. Table 1 shows that after pre-incubation
with Plg, M. bovis EBL cell adherence rates were enhanced by
11.9%. We also noted that proteolysis of the Hubei strain by
trypsin resulted in enhanced adherence to EBL cells; this was more
effective than that observed with Plg alone.
We observed no obvious difference between the anti-rMbEno
antibodies and non-immune rabbit serum in binding inhibition
activity tests (P.0.05), because EBL cells were not treated with
Plg. The inhibition values also showed no obvious differences
between M. bovis pretreated with trypsin by anti-rMbEno antibody
and the non-immune rabbit serum (P.0.05). However, when the
EBL cells were treated with Plg, the anti-enolase antibodies (that
inhibited adherence) were more effective than the non-immune
rabbit antibodies at inhibiting adherence (P,0.05).
Discussion
Identification of the complete genomic sequence of M. bovis
(Hubei strain) a-enolase enabled us to study the a-enolase of this
organism. The M. bovis a-enolase sequence contains the typical
Plg-binding-site motifs that characterize a-enolase proteins.
However, M. bovis a-enolase lacks classical protein-sorting signals.
If the a-enolase is not a surface protein, the function of a-enolase
as a Plg-binding protein in M. bovis may have less biological
significance. However, a-enolase has been shown to be a surface
protein in many bacteria species [11,13,14]. How a-enolase
molecules lacking signal peptides are exported to the cell surface is
an unresolved question. Secretion of a-enolase has been found to
be SecA2-dependent in Listeria monocytogenes [15]; therefore, some
researchers have suggested that a similar mechanism may be used
to export a-enolase [14]. However, if such a mechanism exists, this
presents an important and challenging task that needs to be
addressed by further experimentation. Our experiments suggest
that M. bovis membrane-associated a-enolase is a Plg-binding
protein.
In this study, we have provided evidence that the a-enolase is
present in both the soluble cytosolic fraction and the membrane
fraction of M. bovis; a similar finding has been made in M.
fermentans using transmission electron microscopy [10]. Figur-
e 2(lanes 2 and 3) show the presence of MbEno in both the
membrane and soluble cytosolic protein fractions of M. bovis. This
analysis demonstrates that a-enolase is a membrane-associated
Figure 4. Plasminogen binding assays. Plates were coated as detailed in Materials and Methods.(A) Plasminogen (Plg) (0.5 to 0.007732unit/well)
binds to fixed recombinant Mycoplasma bovis a-enolase (rMbEno) in a concentration-dependent manner. (B) In a parallel assay, Plg (0.5 to 0.007732/
units) binds to whole cell proteins in a concentration-dependent manner. (C) In a competition assay, binding of plasminogen is inhibited by
increasing concentrations of anti-rMbEno antiserum (in serial dilutions from 1/100 to 1/6400). (D) Negative control: Plasminogen binding is inhibited
by an anti-M. bovis monoclonal antibody. Three independent experiments were performed in triplicate. The error bars indicate the standard
deviations from three independent experiments.
doi:10.1371/journal.pone.0038836.g004
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species [9–12]. We suggest that the presence of a-enolase in this
location is consistent with the etiology of adherence to host cells.
That a-enolase plays a role in the invasion of host tissue by
pathogens exhibiting adhesion has already been demonstrated
[13]. Recent studies indicated that a-enolase on the cell surface of
Streptococcus pneumoniae and M. fermentans binds and activates
plasminogen [10,16] and influences Streptococcus pneumoniae adher-
ence to human pharyngeal cells [16]. a-enolase confers surface-
associated proteolytic activity, which may facilitate pathogen
invasion and dissemination in the infected host [9].
Interestingly, western immunoblot assays revealed that several
different proteins within the M. bovis membrane protein fraction
bound to Plg. Figure 4 shows that the rabbit anti-rMbeno antibody
inhibits the binding of Plg to M. bovis whole-cell proteins,
supporting our hypothesis that a-enolase is a major Plg-binding
protein in M. bovis.
Our research supports the hypothesis that the M. bovis a-enolase
is a Plg-binding protein, and we speculate that a-enolase is
involved in M. bovis adhesion to EBL cells. The triple immuno-
fluorescence labeling technique used here, when combined with
CLSM, offers a visual way to differentiate between adherence and
adherence inhibition in mycoplasmas. Utilization of CLSM
revealed that the degree of M. bovis adherence to the cell surface
of EBL cells is related to the availability of Plg and a-enolase.
The adherence and inhibition assay results confirm that Plg
facilitates the binding of M. bovis to EBL cells. Surprisingly,
proteolysis of M. bovis by trypsin resulted in significantly enhanced
binding to EBL cells in comparison with Plg alone, and the
enhancement was not specifically inhibited by the addition of anti-
Figure 5. Confocal laser scanning microscopy depicting interactions between the Mycoplasma bovis Hubei strain and embryonic
bovine lung (EBL) cells. EBL cells prtreated with plasminogen (Plg) were infected for 4 h M. bovis (Hubei) (MOI =200). The infected melanoma cells
were washed, fixed, and immunostained with bovis anti-M. bovis antibody and rabbit anti-bovine IgG–FITC. Membranes containing EBL cells were
labeled with 1,19-dioctadecyl-3,3,39,39-tetramethylindocarbocyanine perchlorate (DiI)and cell nuclei counter-labeled with 49,6-diamidino-2-
phenylindole (DAPI).(A1–A2) EBL cells prtreated with Plg were infected with the Mycoplasma bovis Hubei strain.(B)The adherence process is
inhibited by anti-rMbEno antidody(20 ug/ml).(C) In a competition assay, adherence process was inhibited by non-immune rabbit antibodies (20 ug/
ml) (D) Uninfected M. bovis EBL cell control.
doi:10.1371/journal.pone.0038836.g005
Table 1. Adherence and inhibition assays.
antibodies Pretreatments
HBSS (%)
Plasminogen
(0.25unit/ml) (%)
Trypsin
(25mg/ml) (%)
Negative control 100 111.9 234.9
Non-immune
rabbit antibody
59.4 69.9* 39.7
Rabbit
Anti-enolase
antibody
57.0 58.8* 37.6
Experiments were performed in triplicate. Hank’s Balanced Salt Solution (HBSS).
*P,0.05, compared with the corresponding group using non-immune rabbit
antibodies.
doi:10.1371/journal.pone.0038836.t001
a-Enolase of Mycoplasma bovis
PLoS ONE | www.plosone.org 4 June 2012 | Volume 7 | Issue 6 | e38836rMbeno antibody. This result suggests that other protease-binding
regions in the M. bovis cell membrane are involved in proteolysis,
as has been described previously [17], and that these regions
enhance Mycoplasma adherence to host cells. Some research has
shown that proteases such as trypsin and proteinase K reduced
mycoplasma binding to cells by hydrolyzing the surface adhesion-
related protein [18]. We believe that the presence of large
numbers of proteases would reduce binding by hydrolysis of
surface proteins; however, in the presence of trace amounts of
protease, the protease would enhance binding by giving myco-
plasmas proteolytic activity. Essentially, whether protease pre-
treatment makes mycoplasmas more effective at binding cells is
probably dependent on the concentration of the protease itself and
the reaction conditions present at the time.
a-enolase has been detected in studies attempting to identify
proteins interacting with host surfaces in bacteria [12,16]. To
functionally characterize the M. bovis a-enolase, both the
recombinant and the native proteins were subjected to an in vitro
plasminogen-binding assay. In this work we have demonstrated
the ability of M. bovis a-enolase to bind Plg; this could be of great
importance for Mycoplasma establishment in the host, allowing
adhesion to the EBL cells. Other studies have shown that a-
enolase is not only an adhesion-related factor, but also an auto-
antigen in connective tissue diseases [19]. We speculate that a-
enolase may be involved in various clinical and pathologic
sequelae of M. bovis infection, such as arthritis, tenosynovitis and
meningitis.
Conclusions
In conclusion, our studies show that the a-enolase of M. bovis is a
surface-exposed protein that enables M. bovis adherence to EBL
cells by binding Plg. Howere, several other Plg receptors exist on
the M. bovis cell surface. Our finding that trypsin enhances
adherence more effectively than does Plg is noteworthy and may
provide some insight towards identifying the mechanisms under-
lying M. bovis adherence to host cells.
Materials and Methods
Ethics Statement
Animal experiments were approved by Harbin Veterinary
Research Institute of the Chinese Academy of Agricultural
Sciences and National Engineering Research Center of Veterinary
Biologics. And animal experiments were performed in accordance
with animal ethics guidelines and approved protocols. The Animal
Ethics Committee approval number was Heilongjiang-SYXK
2006-032.
Bacterial strains, cell lines, and culture conditions
The M. bovis strain Hubei isolated in China [6], was used in this
study. In these experiments, mycoplasmas were grown in modified
pleuropneumonia-like organism (PPLO) medium containing 20%
donor equine serum(Hyclone, Logan, USA), 10% yeast extract,
thallium acetate (0.125 mg/ml) and penicillin (200 IU/ml) [20].
The EBL cells [21] were kindly provided by Pro. Xue (National
Engineering Research Center of Veterinary Biologics, Harbin,
China).
Cloning, M. bovis a-enolase gene expression, and protein
purification
The a-enolase ORF was identified from the M. bovis strain
Hubei strain complete genome sequence [22]. The M. bovis a-
enolase ORF containing two TGA codons, which were in vitro
terminators, encoded tryptophan in Mycoplasma. Primers eno1/
eno2, eno3/eno4 and eno5/eno6 (Table 2) were designed for site-
directed mutagenesis and used in overlapping PCRs. The full-
length mutated gene was expressed by pET System (Novagen,
Madison, USA). The resulting rMbEno protein was purified using
HisPur Ni-NTA Resin and Kits (Thermo, Rockford, USA).
Antibody production
Polyclonal antibodies against M. bovis a-enolase were prepared
in female New Zealand White rabbits by injection with rMbEno
protein. The rabbits were bled ten days after the third
immunization and the antibody titers measured by ELISA.
Antibodies were purified using Protein A High-Capacity Agarose
and Kits (Thermo) and quantified using a BCA Protein Assay
Kit(Beyotime Institute of Biotechnology, Nan Tong, China).
Preparation of M. bovis protein fractions
Membrane and cytosolic protein fractions from M. bovis were
obtained using ProteoExtract Transmembrane Protein Extraction
Kit (Novagen) according to the manufacturer’s instructions. Whole
cell protein extracts were prepared by sonication. Protein
quantitation was performed with the BCA Protein Assay Kit.
Cellular localization of M. bovis a-enolase
To locate the cellular distribution of MbEno, Western
immunoblot assays were performed as described previously [14].
Briefly, the gels were transferred to nitrocellulose membranes
(PALL, Ann Arbor, USA) and blocked with 5% gelatin derived
from cold-water fish skin (Sigma). Following three washes with
PBST (PBS containing 0.05% Tween-20), nitrocellulose(NC)
membrane was incubated with anti-rMbEno antibody(1:800).
Bound antibodies were detected by incubation with anti-rabbit
IgG (whole-molecule) peroxidase conjugate (Sigma). Cross react-
ing protein bands were visualized using a DAB Substrate Kit
(Thermo).
M. bovis a-enolase plasminogen binding assays
A ligand blotting assay was performed to test the ability of the
M. bovis a-enolase to bind plasminogen, as described previously
Table 2. Overlapping PCR primers using for amplification of a-Enolase.
Primers name Sequence (59R39) Localization (nt)
Eno1
Eno2
Eno3
Eno4
Eno5
Eno6
cag gga tcc atg cct att att gaa aca att caa g tca taa
cac ctttgc cgc cga acc agt ttc ctt cggc cgc aaa ggt
gtt atg aca gcc gtt gat aat gtt a
tcg ctt tca gca aga cca tct tca att gaa ata ata gga t tct
tgc tga aag cga ttg gga agg att tgc aaa aat gac t cgg
gtc gac tta ctt tat gtt gta aaa tgc ttt aga acc
1–186
186–960
960–1365
doi:10.1371/journal.pone.0038836.t002
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transferred onto NC membranes, and incubated with Plg (Sigma).
Blots were developed with DAB Substrate Kit.
ELISA was performed to verify the ability of the proteins to
bind Plg [14]. ELISA plate wells were coated with rMbEno. In a
parallel experiment, ELISA wells were coated with membrane
protein fraction from M. bovis cells and a range of concentrations of
Plg added to the wells. The inhibition experiment was performed
by adding anti-rMbEno antibody (in serial dilutions from 1/100 to
1/6,400) prior to the addition of Plg. A set of competition
experiments were also performed that included the addition of
anti-M. bovis monoclonal antibody (Abcam, Hong Kong, China).
Protein-protein interactions were identified through use of sheep
anti-plasminogen polyclonal antibodies. The binding was deter-
mined by incubation with anti-sheep antibodies. The absorbance
was measured at A450 using a microplate reader (Bio-Tek
Instruments, Winooski, USA).
Adherence and inhibition assay of M. bovis
Invasion of M. bovis strain Huibei was determined using CLSM
[23]. After washing to remove non-adherent mycoplasmas, M.
bovis-infected EBL cells were fixed with 4% paraformaldehyde
(PFA). The dish containing the cells was overlaid with anti-M. bovis
antiserum. Antibodies bound to the cells were detected by rabbit
anti-bovine IgG (whole molecule)–FITC (Sigma). The membranes
containing EBL cells were labeled with 1,19-dioctadecyl-3,3,39,39-
tetramethylindocarbocyanine perchlorate (DiI). Cell nuclei were
labeled with 49,6-diamidino-2-phenylindole (DAPI). Immunofluo-
rescent was evaluated using a Leica TCS SP5 laser scanning
confocal microscope (Leica, Mannheim, Germany).
Adherence and inhibition of adherence was determined using a
bacteriological assay, as described previously [24]. Plg(0.25 units/
ml) was incubated with EBL cells. The cells then were infected
with M. bovis (Hubei) at a multiplicity of infection (MOI) of 200.
Non-adherent mycoplasmas were removed by washing. The cells
were lysed with 0.25% trypsin (Gibco) and serial dilutions of the
cell lysate were plated onto solid modified PPLO medium. The
Mycoplasma colonies were counted to determine the adherence
frequencies. For the adherence inhibition assay, M. bovis (Hubei)
was incubated with rabbit antibody raised against rMbEno
(20 mg/ml), or non-immune rabbit antibody (20 mg/ml) prior to
infecting the EBL cells (as described above). And a parallel
experiment was performed by replacing the native M. bovis
preparation in the adherence reaction mixture with M. bovis that
had been pre-incubated with trypsin (25 mg/ml) for 15 min at
37uC (all steps thereafter were performed as described above). The
percent inhibition was calculated using the following formula:
(CFU each cell treated with rabbit antibody/CFU each untreated
cell) 6100.
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